Sensorion announced the appointment of five renowned experts to its Scientific Advisory Board (SAB). The SAB is chaired by Professor Christine Petit, MD, PhD, a globally renowned geneticist and neurobiologist with decades of hearing research leadership who has recently received the Kavzli Prize in Neuroscience and was appointed as Director of the French Hearing Institute, in addition to her other current roles. The new members of the SAB are Professor Alain Fischer, Dr. Robert Dow, Professor Paul Avan, Dr. Diane Lazard and Dr. Hernán López-Schier. Professor Fischer has an extensive scientific and medical career. He led pioneering research on gene therapy, primary immunodeficiency diseases, and the development of the lymphoid system. He is currently Professor at Collège de France and has held a number of other prestigious positions, including founding member and director of the Institute for Genetic Diseases (Imagine) at Necker University Hospital. Dr. Dow has more than 37 years’ experience in pharmaceutical and biotech industry, during which he has held a variety of senior executive positions at Syntex Corporation, Hoffman La Roche, Cell Genesys Inc. and more recently as Chief Medical Officer at PPD Inc. He has substantial experience across a broad range of therapeutic areas in managing the transition of medicinal products from pre-clinical to clinical development and through Phase III. Dr. Dow also has substantial experience in regulatory interactions in the USA and Europe. Professor Avan is both a physicist and a medical doctor in biophysics. He designed original objective methods of exploration of the cochlea and auditory pathways. The tests developed have been applied to diagnosis in patients and led to the design of novel electrophysiological equipment detecting formerly inaccessible parameters. He is currently head of the Center for Research and Innovation in Human Audiology (CERIAH) at the Institut de l'Audition in Paris, France. Dr. Lazard is an ENT surgeon with the main research topic of cortical plasticity induced by deafness, and its links to cochlear implantation outcome. She is Principal Associate Investigator in a team at the Hearing Institute in Paris, where she is currently pursuing research on deciphering language processing variability in deafness. Dr. López-Schier is Senior Group Leader and Research Unit Director at the Helmholtz Center in Munich, Germany. His research focuses on fundamental sensory biology and sensory dysfunction, and his group was the first to visualize the regeneration of mechanosensory hair cells in their natural context.